Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: hematemesis major surgical or invasive procedure: egd history of present illness: admit note reviewed. 47 yo m c type i dm c/b retinopathy, neuropathy, nephropathy. developed post nasal drip and subsequent retching 1 d pta. continued to have coughing/retching. started to vomit combination of secretions and gastric contents followed by coffee grounds. came to ed complaining of vomiting and weakness. noted to be hypertensive in ed, given beta blocker. underwent ng lavage which did not clear. admitted to . in , hd stable, no transfusions, kept on iv ppi, npo; plan for egd today. past medical history: 1)dm1- diabetic triopathy- retinopathy, neuropathy, nephropathy alb/cre ratio 430, hbaic 10.7, flu vaccine , followed by dr. at 2)hypercholesterolemia 3)iron defeciency anemia 4)hypertension 5)goiter 6)depression 7)cri- cr 1.0 8)colonic polyp 9)l foot osteomyelitis ' 10)diabetic autonomic neuropathy- +tilt table test social history: retired boat captain; used to work in and . on disability. smoked 30 pack years; quit 1 y ago. no etoh, recreational marijuana use. family history: no diabetes. grandfather died of mi , grandmother died mi at 68 physical exam: vs - 86, 121/41, 99%, 14 heent - op clear, mmm, no lad, pink conjunctivae lungs - cta heart - rrr, s1, s2, no rmg abd - soft, nt, nd, bs+ ext - wwp, no cce; denuded below midshin. proprioception intact at r ankle, none at left. pertinent results: admit labs: 10:45pm hct-28.0* 06:54pm pt-12.5 ptt-22.5 inr(pt)-1.1 06:45pm glucose-341* urea n-22* creat-1.2 sodium-142 potassium-3.6 chloride-106 total co2-19* anion gap-21* 06:45pm alt(sgpt)-24 ast(sgot)-18 alk phos-95 amylase-83 tot bili-0.5 06:45pm lipase-13 06:45pm wbc-11.6*# rbc-3.71* hgb-11.4* hct-31.9* mcv-86 mch-30.8 mchc-35.8* rdw-13.5 06:45pm neuts-83.4* lymphs-13.8* monos-2.1 eos-0.7 basos-0.1 06:45pm plt count-233 . discharge labs: 05:45am blood wbc-8.1 rbc-3.46* hgb-10.7* hct-29.5* mcv-85 mch-31.0 mchc-36.3* rdw-13.9 plt ct-185 05:45am blood plt ct-185 05:45am blood glucose-70 urean-11 creat-0.9 na-139 k-3.9 cl-107 hco3-25 angap-11 05:45am blood calcium-8.5 phos-2.9 mg-2.0 . egd: + hemorrhagic gastritis, no ulcers. . hpylori serology - negative . uctx - group b strep 10k-100k brief hospital course: a/p: 47 yo m c type i dm c complications and known peptic ulcer disease p/w hematemesis. . hematemesis - ddx included esophageal pathologies (- (especially in context of cough), varices), gastric etiologies including gastritis, ulcer disease, duodenal etiologies including ulcer; also vascular lesions (dieulafoy). initially admitted to for close monitoring, kept npo c 2 large bore ivs. monitored with serial hct, iv ppi . egd done showing hemorrhagic gastritis, no esophageal/gastric pathology --> pt. started on regular diabetic diet. discharged hd stable c stable crit on solids. did not require transfusions. . hypertension - has history of orthostatic hypotension likely autonomic neuropathy. unclear why pt. hypertensive in ed. received beta blocker in ed. continued . remained normotensive on discharge. . diabetes - multiple complications poor control - no evidence dka. continued on sliding scale. received several doses of lantus at less than usual dose given pt. npo. advised pt. to follow up with clinic. . iron def anemia - on iron supplement; continued. colonoscopy has not been done; should be discussed as outpt. . depression - continued outpt. regimen of ssri/mirtazapine medications on admission: meds: cozaar 25' protonix 40' remeron 15' fluoxetine 30' lipitor 10' lantus 24' humalog 30 u asa 81 vit d meds on transfer: atorvastatin 20 qhs riss ferrous sulfate 325 fluoxetine 30 qd mirtazapine 15 qhs vitamin d 400 qd losartan 25 qd pantoprazole 40 iv q12 anzemet prn docusate prn bisacodyl prn discharge medications: 1. losartan 25 mg tablet sig: one (1) tablet po daily (daily). 2. mirtazapine 15 mg tablet sig: one (1) tablet po hs (at bedtime). 3. fluoxetine 10 mg capsule sig: three (3) capsule po daily (daily). 4. cholecalciferol (vitamin d3) 400 unit tablet sig: one (1) tablet po daily (daily). 5. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed for constipation. disp:*30 capsule(s)* refills:*0* 6. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed for constipation. disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 7. ferrous sulfate 325 (65) mg tablet sig: one (1) tablet po bid (2 times a day). disp:*30 tablet(s)* refills:*2* 8. atorvastatin 20 mg tablet sig: one (1) tablet po hs (at bedtime). 9. acetaminophen 325 mg tablet sig: one (1) tablet po q4-6h (every 4 to 6 hours) as needed for fever. 10. insulin glargine subcutaneous 11. humalog subcutaneous 12. protonix 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po twice a day. disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* discharge disposition: home discharge diagnosis: primary 1. hematemesis 2. hemorrhagic gastritis secondary 1. type i diabetes discharge condition: good discharge instructions: you should follow up with your pcp weeks. you should follow up with the clinic for your diabetes care as well. you should return to the er and/or contact your pcp if you have further chest pain, shortness of breath, nausea, vomiting, light headedness, dizziness, or blood in your stools. you should take all your medications as directed. followup instructions: provider: , dpm phone: date/time: 9:50 . follow up with dr. , your pcp 1 week. md procedure: other endoscopy of small intestine diagnoses: nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere pure hypercholesterolemia unspecified essential hypertension polyneuropathy in diabetes depressive disorder, not elsewhere classified unspecified gastritis and gastroduodenitis, with hemorrhage iron deficiency anemia, unspecified diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled 

Answer: The patient is high likely exposed to